ZimVie (ZIMV) to Release Quarterly Earnings on Wednesday

ZimVie (NASDAQ:ZIMV) is anticipated to issue its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $108.80 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, November 5, 2025 at 3:30 PM ET.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings results on Monday, April 1st. The company reported $0.07 earnings per share for the quarter. ZimVie had a positive return on equity of 6.37% and a negative net margin of 4.39%.The business had revenue of ($221.45) million during the quarter.

ZimVie Stock Performance

NASDAQ:ZIMV opened at $18.99 on Monday. ZimVie has a 1-year low of $8.15 and a 1-year high of $19.01. The firm has a market capitalization of $535.71 million, a price-to-earnings ratio of -27.13 and a beta of 2.17. The company has a quick ratio of 1.60, a current ratio of 2.37 and a debt-to-equity ratio of 0.56. The stock has a fifty day simple moving average of $18.93 and a 200 day simple moving average of $13.89.

Institutional Investors Weigh In On ZimVie

Several large investors have recently modified their holdings of ZIMV. Main Street Financial Solutions LLC bought a new stake in shares of ZimVie in the second quarter worth about $1,309,000. Qube Research & Technologies Ltd increased its holdings in shares of ZimVie by 43.3% in the second quarter. Qube Research & Technologies Ltd now owns 239,398 shares of the company’s stock worth $2,238,000 after acquiring an additional 72,308 shares in the last quarter. Millennium Management LLC increased its holdings in shares of ZimVie by 7.7% in the first quarter. Millennium Management LLC now owns 707,771 shares of the company’s stock worth $7,644,000 after acquiring an additional 50,805 shares in the last quarter. Gabelli Funds LLC increased its holdings in shares of ZimVie by 38.9% in the second quarter. Gabelli Funds LLC now owns 143,630 shares of the company’s stock worth $1,343,000 after acquiring an additional 40,230 shares in the last quarter. Finally, Quantinno Capital Management LP bought a new stake in shares of ZimVie in the second quarter worth about $375,000. 95.63% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ZIMV. Wall Street Zen downgraded ZimVie from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 18th. Barclays upgraded ZimVie from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $9.00 to $19.00 in a research report on Tuesday, July 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of ZimVie in a research report on Wednesday, October 8th. Finally, B. Riley cut ZimVie from a “buy” rating to a “neutral” rating and set a $19.00 price target on the stock. in a research report on Thursday, July 31st. Four equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $17.75.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.